The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York AOD 9604 The Fat Burning Peptide: Benefits, Mechanism & Safety Much ado about nothing: the peptide they say never worked An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica AOD 9604: The Fat Loss Peptide You'll Soon Be Able to Get Again Meto blog FDA Peptide Reclassification 2026 Amanecia Health